Literature DB >> 24327662

Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.

Vishakha Sovani1, Caroline Harvey, Andrew P Haynes, Andrew K McMillan, David M Clark, Simon R O'Connor.   

Abstract

AIMS: This study aimed to evaluate the key features of bone marrow trephine (BMT) biopsy involvement by lymphoma.
METHODS: 511 cases were assessed for percentage of marrow involvement, pattern of involvement (diffuse, nodular, paratrabecular, interstitial or intrasinusoidal), presence/absence of granulomas, stromal fibrosis and necrosis, presence/absence of neoplastic/reactive follicles and discordance with other biopsy sites. Correlation with aspirate and peripheral blood findings was made in a subset of 345 patients (167 aspirates, 178 blood).
RESULTS: The most frequent subtype was follicular lymphoma (26.2%) followed by extranodal marginal zone (23.1%), lymphoplasmacytic (19.2%), diffuse large B cell (DLBCL) (12.5%), Hodgkin (HL) (5.7%) and mantle cell lymphomas (4.3%). The predominant pattern in follicular lymphoma was paratrabecular. Marginal zone lymphomas of all types and lymphoplasmacytic lymphoma showed a relatively even distribution between diffuse, interstitial, paratrabecular and nodular patterns. The majority of mantle cell lymphoma cases showed either diffuse or nodular patterns. A diffuse pattern was common in DLBCL and Burkitt lymphomas. An intrasinusoidal pattern was seen only in extranodal and splenic marginal zone lymphomas. Granulomas and fibrosis were uncommon in small cell B cell lymphomas but frequent in DLBCL and HL. Aspirate and trephine results concurred in 73.8% of cases overall, but this varied widely between subtypes. Peripheral blood involvement rates by lymphoma also varied, with a mean of 37.1%.
CONCLUSIONS: Different lymphomas often demonstrate reliably characteristic architectural patterns of marrow involvement which can help differentiate them even when cytological features do not permit this, and marrow stromal and other background changes may also be useful pointers towards a particular lymphoma subtype.

Entities:  

Keywords:  Bone Marrow; Bone Marrow Trephines; Haematopathology; Histopathology; Lymphoma

Mesh:

Substances:

Year:  2013        PMID: 24327662     DOI: 10.1136/jclinpath-2013-201520

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

Review 1.  Discordant bone marrow involvement in non-Hodgkin lymphoma.

Authors:  Jennifer Brudno; Tamar Tadmor; Stefania Pittaluga; Alina Nicolae; Aaron Polliack; Kieron Dunleavy
Journal:  Blood       Date:  2015-12-17       Impact factor: 22.113

2.  Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.

Authors:  M A Cabezas-Quintario; P Gomez; V Yuste-Del Pozo; A L Valencia-Mesa; G Sosa; P Ricard; A I Hijas-Gómez; F Pinedo; M Arguelles
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

3.  Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.

Authors:  Hugo J A Adams; Thomas C Kwee; Rob Fijnheer; Stefan V Dubois; Peter E Blase; Rutger A J Nievelstein; John M H de Klerk
Journal:  Skeletal Radiol       Date:  2014-06-06       Impact factor: 2.199

4.  B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.

Authors:  Leo Zhang; Krystle Nomie; Hui Zhang; Taylor Bell; Lan Pham; Sabah Kadri; Jeremy Segal; Shaoying Li; Shouhao Zhou; David Santos; Shawana Richard; Shruti Sharma; Wendy Chen; Onyekachukwu Oriabure; Yang Liu; Shengjian Huang; Hui Guo; Zhihong Chen; Wenjing Tao; Carrie Li; Jack Wang; Bingliang Fang; Jacqueline Wang; Lei Li; Maria Badillo; Makhdum Ahmed; Selvi Thirumurthi; Steven Y Huang; Yiping Shao; Laura Lam; Qing Yi; Y Lynn Wang; Michael Wang
Journal:  Clin Cancer Res       Date:  2017-03-27       Impact factor: 12.531

5.  Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China.

Authors:  Yun-Fei Shi; Xiang-Hong Li; Yu-Qin Song; Wei-Wei Song; Yu-Mei Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET-CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma.

Authors:  Mesut Göçer; Erdal Kurtoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-05-04       Impact factor: 0.900

7.  BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase.

Authors:  Dehui Zou; Shuhua Yi; Rui Cui; Wei Liu; Chengwen Li; Shizhen Zhong; Zhen Yu; Zengjun Li; Rui Lv; Kun Ru; Huijun Wang; Gang An; Yan Xu; Lugui Qiu
Journal:  BMC Med Genet       Date:  2017-02-16       Impact factor: 2.103

8.  How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution.

Authors:  Woo-Jae Kwoun; Jeong-Yeal Ahn; Pil-Whan Park; Yiel-Hea Seo; Kyung-Hee Kim; Ja Young Seo; Hwan Tae Lee; Kuai-Han Yoo
Journal:  J Clin Lab Anal       Date:  2019-02-06       Impact factor: 2.352

9.  Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.

Authors:  Mihai Merzianu; Adrienne Groman; Alan Hutson; Claudiu Cotta; Russell K Brynes; Attilio Orazi; Vishnu Reddy; Julie Teruya-Feldstein; Ramila Amre; Manjula Balasubramanian; Guilherme Brandao; Sindhu Cherian; Elizabeth Courville; David Czuchlewski; Guang Fan; David Grier; Daniela Hoehn; Kedar V Inamdar; Ridas Juskevicius; Prabhjot Kaur; John Lazarchick; Michael R Lewis; Rodney R Miles; Jerome B Myers; Michel R Nasr; Hina N Qureishi; Horatiu Olteanu; Valentin G Robu; Gratian Salaru; Neerja Vajpayee; Jeffrey Vos; Ling Zhang; Shanxiang Zhang; Le Aye; Elisa Brega; James E Coad; John Grantham; Sinisa Ivelja; Robert McKenna; Kieran Sultan; Gregory Wilding; Robert Hutchison; LoAnn Peterson; Richard T Cheney
Journal:  Am J Clin Pathol       Date:  2018-10-01       Impact factor: 2.493

Review 10.  The broad landscape of follicular lymphoma: Part II.

Authors:  Stefano Fratoni; Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Valentina Aimola; Giulia Cerrone; Linda Ricci; Alessandra Filosa; Giovanni Martino; Antonella Maria Fara; Valerio Annessi; Alessandra Soriano; Stefano Ascani
Journal:  Pathologica       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.